Health and Medicine
U.S. could apply U.K.’s approach to evaluate safety, ethics
Two potential ways of stamping out serious disease by manipulating the genomes of human embryos are under intense public debate: mitochondrial replacement therapy and germline genome editing. The UK has already approved the former. Its process could guide the U.S. as it considers allowing either or both of the techniques.
Read Article